Clinical trial
NAsal Polyps: Inflammatory & Molecular Phenotyping of Responders to Benralizumab
NCT04185012 is registered in ClinicalTrials.gov with Humanitas Clinical and Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NAsal Polyps: Inflammatory & Molecular Phenotyping of Responders to Benralizumab
- Lead sponsor
- Humanitas Clinical and Research Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 24, 2020
- Completion date
- June 28, 2024
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.